| Primary |
| Hypothyroidism |
46.2% |
| Product Used For Unknown Indication |
30.8% |
| Autoimmune Thyroiditis |
3.8% |
| Blood Growth Hormone Abnormal |
3.8% |
| Blood Thyroid Stimulating Hormone Decreased |
3.8% |
| Hashimoto's Disease |
3.8% |
| Secondary Hypothyroidism |
3.8% |
| Urinary Tract Infection |
3.8% |
|
| Product Substitution Issue |
17.6% |
| Thyroid Function Test Abnormal |
11.8% |
| Glossitis |
5.9% |
| Hepatotoxicity |
5.9% |
| Hypertension |
5.9% |
| Product Quality Issue |
5.9% |
| Secondary Hypogonadism |
5.9% |
| Sinus Disorder |
5.9% |
| Syncope |
5.9% |
| Tardive Dyskinesia |
5.9% |
| Therapeutic Response Unexpected With Drug Substitution |
5.9% |
| Vitamin B12 Deficiency |
5.9% |
| Weight Decreased |
5.9% |
| Weight Increased |
5.9% |
|
| Secondary |
| Product Used For Unknown Indication |
54.5% |
| Foetal Exposure Timing Unspecified |
18.2% |
| Chronic Obstructive Pulmonary Disease |
6.8% |
| Hypoparathyroidism |
6.8% |
| Hypothyroidism |
4.5% |
| Blood Cholesterol Increased |
2.3% |
| Hypertension |
2.3% |
| Intertrigo |
2.3% |
| Smoking Cessation Therapy |
2.3% |
|
| Tremor |
22.2% |
| Foetal Growth Restriction |
11.1% |
| Hypertension |
11.1% |
| Micturition Urgency |
11.1% |
| Product Substitution Issue |
11.1% |
| Renal Failure Acute |
11.1% |
| Sinus Bradycardia |
11.1% |
| Urticaria |
11.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
59.6% |
| Rheumatoid Arthritis |
5.9% |
| Depression |
3.8% |
| Hepatitis C |
3.7% |
| Hypertension |
3.5% |
| Hypothyroidism |
3.3% |
| Drug Use For Unknown Indication |
3.2% |
| Bipolar Disorder |
2.4% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Multiple Sclerosis |
1.5% |
| Sleep Disorder |
1.5% |
| Pain |
1.4% |
| Blood Cholesterol Increased |
1.3% |
| Crohn's Disease |
1.3% |
| Psoriatic Arthropathy |
1.1% |
| Diabetes Mellitus |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Insomnia |
1.0% |
| Psoriasis |
1.0% |
| Schizoaffective Disorder |
1.0% |
|
| Drug Ineffective |
10.2% |
| Injection Site Pain |
9.8% |
| Sinusitis |
8.1% |
| Vomiting |
8.1% |
| Pain |
5.6% |
| Pain In Extremity |
5.6% |
| Therapeutic Response Decreased |
5.3% |
| Weight Decreased |
4.6% |
| Injection Site Bruising |
4.2% |
| Injection Site Reaction |
4.2% |
| Urinary Tract Infection |
4.2% |
| Weight Increased |
4.2% |
| Injection Site Swelling |
3.9% |
| Pruritus |
3.9% |
| Death |
3.5% |
| Nasopharyngitis |
3.5% |
| Injection Site Pruritus |
2.8% |
| Nausea |
2.8% |
| Oropharyngeal Pain |
2.8% |
| Pyrexia |
2.8% |
|
